DepartmentSteffenDepartmentFauthDepartmentFlorianDepartmentKrienerDepartmentSusanneDepartmentHoelzerDepartmentDieterDepartmentSeipeltDepartmentGernotDepartmentEBSCO_AspLeukemia & LymphomaKoschmieder, S., F. Fauth, et al. (2002). "Effective treatment of simultaneous small cell lung cancer and B-cell lymphoma." Leuk...
238、小细胞肺癌(smallcelllungcancer,SCLC):病例&解析 237、卵巢硬化性间质瘤:病例&解析 236、恶性腹膜间皮瘤:病例&解析 235、粘液纤维肉瘤(myxofibrosarcoma,MFS):病例&解析 234、异位脾种植:病例&解析 233、附睾腺瘤样瘤:病例&解析 232...
Weiskopf K, Anderson KL, Ito D, et al. Eradication of canine diffuse large B-cell lymphoma in a murine xenograft model with CD47 blockade and anti-CD20. Cancer Immunol Res 2016;4:1072–87. Sadowski AR, Gardner HL, Borgatti A, et al. Phase II study of the oral selective inhibitor of ...
Cell Press Scientists are one step closer to developing a targeted therapy for lymphoma. New research, published by Cell Press in the April 13th issue of the journalCancer Cell, identifies a specific small-molecule inhibitor that was nontoxic in animal experiments and could kill human lymphoma cel...
John Seymour,澳大利亚Peter MacCallum癌症中心和皇家墨尔本医院( Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Australia)临床血液科主任。他是多个国家和国际科学委员会的成员,包括澳大利亚癌症顾问团、恶性淋巴瘤国际会议科学顾问委员会、淋巴瘤联盟医学顾问委员会和国际结节外淋巴瘤研究小组等。
Targeted Therapy in Non–Small-Cell Lung Cancer (Beyond Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase)doi:10.1016/B978-0-323-55433-6.00009-2Emily DickinsonDan ZhaoKaren L. ReckampPulmonary Adenocarcinoma: Approaches to Treatment...
Recruitment for this trial at NYU Langone and its Perlmutter Cancer Center is now open. I am also the lead principal investigator on a second phase I treatment study for patients with relapsed and refractory low-grade mantle cell and low-grade B-cell lymphoma (NCT01695941). This trial, ...
intestinal microbiota;inflammation;cancer;lymphoma;prevention 1. Introduction Lymphocytes play a key role in responding to microbial colonization by initiating an immune response leading to tolerance or activation. The majority of immunologically active cells belong to the mucosal-associated immune system and...
Most people with mantle cell lymphoma will begin treatment right after diagnosis and staging of the cancer. But for a small number of people who are otherwise well, have no symptoms, and have a slow-growing form of the cancer, doctors might suggest "watchful waiting." During this time, your...
Rituximab(Rituxan), a monoclonal antibody that sticks to proteins oncancercells and stimulates the immune system to attackcancercells Autologousstem celltransplantation, in which the patient'sstem cellsare removed, stored, and returned to the body ...